Program Layout

Section 1: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum


Section 2: Latest Development in Drug Discovery S & T

Track 2-1: Advanced Drug Discovery Science
Session 211: Pharmacogenetics, Pharmacogenomics and Precision Medicine    
Session 212: Frontiers in Pharmacology and Toxicology
Session 213: Drug Metabolism and Drug Interactions
Session 214: New Advances in Oncology Drug Discovery
Session 215: Innovations in Neuroscience Drug Discovery


Track 2-2: Innovations in Drug Discovery Technologies
Session 221: Innovative Drug Discovery Technology      
Session 222: Novel Analytical Technology in Drug Discovery 
Session 223: Nanotechnology in Drug Discovery
Session 224: Emerging Drug Screening Technology
Session 225: Computer-aided Drug Discovery and Development


Stream 3: Breaking Preclinical Research and Development
Track 3-1: Novel Targets in Drug Discovery
Session 311: Cancer Drug Targets     
Session 312: CNS and Neurodegenerative Drug Targets 
Session 313: Autoimmune and Inflammation Drug Targets
Session 314: Emerging Drug Targets for Metabolic Disorders
Session 315: Infectious Disorders Drug Targets      


Track 3-2: Latest Insights into Drug Discovery Chemistry
Session 321: Open Innovation in Drug Discovery    
Session 322: New Achievements in Drug Design and Synthesis 
Session 323: Lead Discovery: Screening and Optimization
Session 324: Emerging Kinase Targets and Kinase Inhibitor Discovery
Session 325: New Insights into Small Molecule Drug Discovery


Stream 4: From Clinical Applications to Drug Manufacturing
Track 4-1: Recent Advances in Clinical Applications
Session 411: Cancers/Tumors    
Session 412: CNS Diseases      
Session 413: Infectious Diseases      
Session 414: Cardiovascular Diseases     
Session 415: Diabetes and Other Metabolic Disorders
Session 416: Inflammation and Immunological Diseases
Session 417: Digestive System Diseases
Session 418: Orphan Diseases & Other Diseases
Session 419: Pharmacovigilance, Drug Safety and Risk Management


Track 4-2: Emerging Trends for Biotherapy
Session 421: Recent Advances in Immunotherapy     
Session 422: Development of Therapeutic Antibodies, Vaccines and Antibodyomes     
Session 423: Catch the New Wave of Protein and Peptide Therapy
Session 424: Cell and Gene Therapy: Translational Development and Clinical Applications


Track 4-3: Advanced Natural Products
Session 431: Natural Product Discovery   
Session 432: Application of Natural Products


Track 4-4: Drug Bioprocessing & Manufacturing and Integrative Services
Session 441: New Challenges in Future Pharma Manufacturing    
Session 442: Frontiers in Novel Biosimilars     
Session 443: CMO/CRO and Outsourcing Services 
Session 444: Pharma Policy, Regulations and Marketing Trends   

Stream 5: Young Scientist Forum


© 2003-2022 All rights reserved by BIT Congress
Contact Us: Tel:0086-411-84799609,